Clinical Trials in Austin

Showing 721-740 of 13,060 trials

A Trial of TAK-861 for the Treatment of Narcolepsy With Cataplexy

NCT07363720

The main aim of this study is to assess how effective TAK-861 is for treating narcolepsy type 1 and if this effect is maintained over time. Participants will take TAK-861 for a few months and if they meet certain criteria, they will be randomly assigned (by chance, like flipping a coin) to continue taking TAK-861 or take placebo (fake medicine) for up to 4 weeks to see if their narcolepsy symptoms return.

Narcolepsy Type 1 (NT1)Narcolepsy With Cataplexy

Takeda88 participantsStarted Jan 2026

Redwood City, California, United States • Brandon, Florida, United States • Miami, Florida, United States +4 more locations

Active Not RecruitingPhase 262 miles

Dinaciclib in Treating Patients With Stage IV Melanoma

NCT00937937

This phase II trial is studying the side effects and how well dinaciclib works in treating patients with stage IV melanoma. Dinaciclib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

Acral Lentiginous MelanomaCutaneous Nodular MelanomaLentigo Maligna Melanoma+4 more

National Cancer Institute (NCI)72 participantsStarted Jul 2009

Mobile, Alabama, United States • Fort Smith, Arkansas, United States • Little Rock, Arkansas, United States +187 more locations

A Trial of TAK-861 for the Treatment of Narcolepsy With Cataplexy

Dinaciclib in Treating Patients With Stage IV Melanoma

Find Trials by Condition in Austin

Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer

A U.S. Registry of Eosinophilic Esophagitis Pediatric, Adolescent and Adult Patients Treated With DUPIXENT® As Standard of Care

A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis.

Bomedemstat vs Hydroxyurea for Essential Thrombocythemia (MK-3543-007)

Molecular Profiling in Tissue Samples From Patients With Cancer Who Are Exceptional Responders to Treatment

A Study of PYX-201 in Advanced Solid Tumors

Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery

CASCADE-LUNG: Cancer Screening Assay Using DELFI; A Clinical Validation Study in Lung

Targeted Pediatric High-Grade Glioma Therapy

Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors

Varithena Versus Endothermal Ablation of the Great Saphenous Vein (VERITAS)

Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial

A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer

Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment

Testing the Addition of an Anti-cancer Drug, ASTX727 (Cedazuridine, Decitabine), to Chemotherapy (Paclitaxel) and Immunotherapy (Pembrolizumab) for Metastatic Triple-Negative Breast Cancer

Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma

A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014)